Capricor Therapeutics (CAPR) Q2 2024 Earnings

13MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-0.35
-0.24
-0.13
-0.02

Details

Expected EPS
-0.1137
Actual EPS
-0.31
Surprise EPS
-0.2
Surprise Percent
+172.65%

Description

Capricor Therapeutics (CAPR) has reported earnings of -0.31 per share for Q2 2024.

0 Comments

Share your thoughts